Atlas Trials

A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer

Clinical trial NCT03788226 · UNKNOWN

Trial details

NCT number
NCT03788226
Sponsor
Fujian Cancer Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Gastric Cancer Stage III
Start date
2019-02-01
Primary completion
2021-12-31
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.